Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of nonproliferative diabetic retinopathy, researchers have found. Data from two phase 3 trials — Pagoda and Pavilion — demonstrate how the delivery system, which the US Food and Drug Administration approved […]
The post Port System Cuts Injection Burden in Diabetic Eye Disease first appeared on News Health.
Author : News Health
Publish date : 2025-03-11 08:25:00
Copyright for syndicated content belongs to the linked Source.